- Article metrics
- Last updated: Thu, 16 Oct 2025 1:15:12 Z
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
Access & Citations
-
- 68k
- Article Accesses
-
- 723
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 1 tweeters
- 2 blogs
- 1 Wikipedia page
- 718 Mendeley
- 2 Citeulike
This article is in the 95th percentile (ranked 2,808th) of the 64,613 tracked articles of a similar age in all journals and the 96th percentile (ranked 6th) of the 185 tracked articles of a similar age in Oncogene
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Landmark Nephrology: Use of Rituximab in Lupus Nephritis
Renal Fellow Network -
Landmark Trials on the use of Rituximab in ANCA Associated Vasculitis
Renal Fellow Network
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.